HiberCell commences Phase Ia/b trial of HC-7366 for solid tumours
HiberCell has commenced a first-in-human Phase Ia/b clinical trial of HC-7366 to treat advanced solid tumour patients.
Stay updated with breaking news from Preference Management Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HiberCell has commenced a first-in-human Phase Ia/b clinical trial of HC-7366 to treat advanced solid tumour patients.
The UK MHRA has granted approval to commence a clinical trial of Skymount Medical’s new oral treatments for mild to moderate Covid-19.
OliPass Corporation has initiated the dosing of subjects in Phase IIa trial of pain killer OLP-1002 for osteoarthritis patients with pain.
Unlearn.AI and Merck KGaA have signed a partnership to expedite late-stage immunology trials using new designs that comprise Digital Twins.
After a series of disappointing clinical trial data in Huntington’s disease, study design changes take aim at moving the field forward.